These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16098701)

  • 1. Challenges and opportunities for enhancing biotechnology and technology transfer in developing countries.
    Salicrup LA; Fedorková L
    Biotechnol Adv; 2006; 24(1):69-79. PubMed ID: 16098701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies.
    Ma JK; Christou P; Chikwamba R; Haydon H; Paul M; Ferrer MP; Ramalingam S; Rech E; Rybicki E; Wigdorovitz A; Yang DC; Thangaraj H
    Plant Biotechnol J; 2013 Dec; 11(9):1029-33. PubMed ID: 24119183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How can developing countries harness biotechnology to improve health?
    Daar AS; Berndtson K; Persad DL; Singer PA
    BMC Public Health; 2007 Dec; 7():346. PubMed ID: 18053180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unlocking Marine Biotechnology in the Developing World.
    Thompson CC; Kruger RH; Thompson FL
    Trends Biotechnol; 2017 Dec; 35(12):1119-1121. PubMed ID: 28890138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying genomics-related technologies for Africa's health needs.
    Singer PA; Court EB; Bhatt A; Frew SE; Greenwood H; Persad DL; Salamanca-Buentello F; Séguin B; Taylor AD; Daer HT; Daar AS
    Afr J Med Med Sci; 2007; 36 Suppl():7-14. PubMed ID: 17703557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health related biotechnology transfer in Africa: a critique from a capabilities approach.
    Botbol-Baum M
    Afr J Med Med Sci; 2007; 36 Suppl():49-54. PubMed ID: 17703565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotechnology and bioeconomy in China.
    Li Q; Zhao Q; Hu Y; Wang H
    Biotechnol J; 2006 Nov; 1(11):1205-14. PubMed ID: 17109491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health innovation networks to help developing countries address neglected diseases.
    Morel CM; Acharya T; Broun D; Dangi A; Elias C; Ganguly NK; Gardner CA; Gupta RK; Haycock J; Heher AD; Hotez PJ; Kettler HE; Keusch GT; Krattiger AF; Kreutz FT; Lall S; Lee K; Mahoney R; Martinez-Palomo A; Mashelkar RA; Matlin SA; Mzimba M; Oehler J; Ridley RG; Senanayake P; Singer P; Yun M
    Science; 2005 Jul; 309(5733):401-4. PubMed ID: 16020723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of South-North health biotech collaboration.
    Melon CC; Ray M; Chakkalackal S; Li M; Cooper JE; Chadder J; Ke W; Li L; Madkour MA; Aly S; Adly N; Chaturvedi S; Konde V; Daar AS; Singer PA; Thorsteinsdóttir H
    Nat Biotechnol; 2009 Mar; 27(3):229-32. PubMed ID: 19270665
    [No Abstract]   [Full Text] [Related]  

  • 10. Licensing IP to ensure accessibility to vaccines and other immunisation-related products.
    Mehta JM
    Vaccine; 2001 Feb; 19(13-14):1581-7; discussion 1592-3. PubMed ID: 11166878
    [No Abstract]   [Full Text] [Related]  

  • 11. Global health equity in United Kingdom university research: a landscape of current policies and practices.
    Gotham D; Meldrum J; Nageshwaran V; Counts C; Kumari N; Martin M; Beattie B; Post N
    Health Res Policy Syst; 2016 Oct; 14(1):76. PubMed ID: 27724907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BioAsia Licensing and Deal-Making Summit-SRI Conference. Life science partnering and investment on the Pacific Rim 2-3 August, 2004, Coronado, CA, USA.
    Xu J
    IDrugs; 2004 Sep; 7(9):841-5. PubMed ID: 15470601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value creation and sharing among universities, biotechnology and pharma.
    Edwards MG; Murray F; Yu R
    Nat Biotechnol; 2003 Jun; 21(6):618-24. PubMed ID: 12776145
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of health biotechnology in developing countries: can private-sector players be the prime movers?
    Abuduxike G; Aljunid SM
    Biotechnol Adv; 2012; 30(6):1589-601. PubMed ID: 22617902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Legal issues in sharing the benefits of biodiversity prospecting.
    Mays TD; Mazan KD
    J Ethnopharmacol; 1996 Apr; 51(1-3):93-102; discussion 102-9. PubMed ID: 9213633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
    Mitropoulos K; Cooper DN; Mitropoulou C; Agathos S; Reichardt JKV; Al-Maskari F; Chantratita W; Wonkam A; Dandara C; Katsila T; Lopez-Correa C; Ali BR; Patrinos GP
    OMICS; 2017 Nov; 21(11):647-657. PubMed ID: 29140767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology licensing: lessons from the US experience.
    Sobolski GK; Barton JH; Emanuel EJ
    JAMA; 2005 Dec; 294(24):3137-40. PubMed ID: 16380596
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing Countries Vaccine Manufacturers Network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012.
    Pagliusi S; Makhoana M; Datla M; Leite L; Hendriks J; Gholami A; Huang W; Gao Y; Jadhav S; Harshavardhan GV; Wu Y; Suhardono M; Homma A
    Vaccine; 2013 Jun; 31(31):3111-5. PubMed ID: 23684836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIH licensing performance under par.
    Garber K
    Nat Biotechnol; 2004 Dec; 22(12):1607-8. PubMed ID: 15605428
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotechnology to improve health in developing countries -- a review.
    Acharya T; Kennedy R; Daar AS; Singer PA
    Mem Inst Oswaldo Cruz; 2004 Jun; 99(4):341-50. PubMed ID: 15322621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.